Fifth Third Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.48M Sell
3,818
-48
-1% -$17.8K 0.04% 244
2026
Q1
$1.13M Buy
3,866
+320
+9% +$105K 0.04% 252
2025
Q4
$1.24M Buy
3,546
+38
+1% +$12.8K 0.04% 227
2025
Q3
$1.13M Sell
3,508
-417
-11% -$130K 0.04% 221
2025
Q2
$1.53M Buy
3,925
+27
+0.7% +$10.9K 0.06% 191
2025
Q1
$1.7M Buy
3,898
+1,545
+66% +$620K 0.09% 159
2024
Q4
$868K Buy
2,353
+147
+7% +$61.5K 0.05% 224
2024
Q3
$1.15M Buy
2,206
+39
+2% +$20.8K 0.07% 177
2024
Q2
$1.17M Buy
+2,167
New +$1.15M 0.09% 147
2023
Q3
Sell
-526
Closed -$234K 157
2023
Q2
$234K Buy
+526
New +$243K 0.15% 129

Other funds holding ELV

Fifth Third Wealth Advisors's ELV Position: Q2 2026 in Review

Fifth Third Wealth Advisors reduced its Elevance Health (ELV) stake by 1.2% in Q2 2026, selling an estimated $17.8K and leaving 3,818 shares worth $1.48M. The position accounts for 0.04% of the portfolio, ranked #244.

Fifth Third Wealth Advisors first reported a position in ELV in Q2 2023 and has held it in 10 quarters since. The position peaked at $1.7M in Q1 2025. 254 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Fifth Third Wealth Advisors held 3,818 shares of Elevance Health worth $1.48M as of Q2 2026.
  • Fifth Third Wealth Advisors sold 48 Elevance Health shares in Q2 2026, an estimated $17.8K.
  • Elevance Health made up 0.04% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #244 holding.
  • Fifth Third Wealth Advisors first reported a position in Elevance Health in Q2 2023 and has held it in 10 quarters since.
  • Fifth Third Wealth Advisors's Elevance Health position peaked at $1.7M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.